annual cash & cash equivalents:
$344.87M-$13.46M(-3.76%)Summary
- As of today (June 26, 2025), KRYS annual cash & cash equivalents is $344.87 million, with the most recent change of -$13.46 million (-3.76%) on December 31, 2024.
- During the last 3 years, KRYS annual cash & cash equivalents has risen by +$3.62 million (+1.06%).
- KRYS annual cash & cash equivalents is now -3.76% below its all-time high of $358.33 million, reached on December 31, 2023.
Performance
KRYS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$308.77M-$36.09M(-10.47%)Summary
- As of today (June 26, 2025), KRYS quarterly cash & cash equivalents is $308.77 million, with the most recent change of -$36.09 million (-10.47%) on March 31, 2025.
- Over the past year, KRYS quarterly cash & cash equivalents has dropped by -$50.24 million (-13.99%).
- KRYS quarterly cash & cash equivalents is now -23.22% below its all-time high of $402.17 million, reached on March 31, 2021.
Performance
KRYS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KRYS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | -14.0% |
| 3 y3 years | +1.1% | +14.7% |
| 5 y5 years | +83.9% | +71.3% |
KRYS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +113.0% | -17.4% | +119.4% |
| 5 y | 5-year | -3.8% | +113.0% | -23.2% | +119.4% |
| alltime | all time | -3.8% | >+9999.0% | -23.2% | >+9999.0% |
KRYS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $308.77M(-10.5%) |
| Dec 2024 | $344.87M(-3.8%) | $344.87M(-7.8%) |
| Sep 2024 | - | $373.97M(+8.1%) |
| Jun 2024 | - | $345.79M(-3.7%) |
| Mar 2024 | - | $359.01M(+0.2%) |
| Dec 2023 | $358.33M(+121.3%) | $358.33M(-4.0%) |
| Sep 2023 | - | $373.24M(+35.3%) |
| Jun 2023 | - | $275.88M(+96.0%) |
| Mar 2023 | - | $140.75M(-13.1%) |
| Dec 2022 | $161.90M(-52.6%) | $161.90M(-13.1%) |
| Sep 2022 | - | $186.41M(-14.8%) |
| Jun 2022 | - | $218.72M(-18.8%) |
| Mar 2022 | - | $269.30M(-21.1%) |
| Dec 2021 | $341.25M | $341.25M(+19.1%) |
| Sep 2021 | - | $286.61M(-13.0%) |
| Jun 2021 | - | $329.53M(-18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $402.17M(+49.9%) |
| Dec 2020 | $268.27M(+43.1%) | $268.27M(-5.0%) |
| Sep 2020 | - | $282.37M(-3.2%) |
| Jun 2020 | - | $291.68M(+61.8%) |
| Mar 2020 | - | $180.22M(-3.9%) |
| Dec 2019 | $187.51M(+80.9%) | $187.51M(-3.7%) |
| Sep 2019 | - | $194.81M(+4.4%) |
| Jun 2019 | - | $186.59M(+90.4%) |
| Mar 2019 | - | $98.01M(-5.5%) |
| Dec 2018 | $103.67M(+109.1%) | $103.67M(+122.1%) |
| Sep 2018 | - | $46.67M(+11.6%) |
| Jun 2018 | - | $41.81M(-11.5%) |
| Mar 2018 | - | $47.23M(-4.8%) |
| Dec 2017 | $49.59M(+2478.8%) | $49.59M(-5.7%) |
| Sep 2017 | - | $52.57M(+1394.3%) |
| Jun 2017 | - | $3.52M(+82.9%) |
| Dec 2016 | $1.92M | $1.92M |
FAQ
- What is Krystal Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Krystal Biotech?
- What is Krystal Biotech annual cash & cash equivalents year-on-year change?
- What is Krystal Biotech quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Krystal Biotech?
- What is Krystal Biotech quarterly cash & cash equivalents year-on-year change?
What is Krystal Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of KRYS is $344.87M
What is the all time high annual cash & cash equivalents for Krystal Biotech?
Krystal Biotech all-time high annual cash & cash equivalents is $358.33M
What is Krystal Biotech annual cash & cash equivalents year-on-year change?
Over the past year, KRYS annual cash & cash equivalents has changed by -$13.46M (-3.76%)
What is Krystal Biotech quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KRYS is $308.77M
What is the all time high quarterly cash & cash equivalents for Krystal Biotech?
Krystal Biotech all-time high quarterly cash & cash equivalents is $402.17M
What is Krystal Biotech quarterly cash & cash equivalents year-on-year change?
Over the past year, KRYS quarterly cash & cash equivalents has changed by -$50.24M (-13.99%)